Clinical Trial Update: Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of darunavir with cobicistat for COVID-19 pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease
• Pneumonia

Drugs mentioned

• Cobicistat (cobicistat)
• Darunavir (darunavir)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: Pneumonia, Pneumocystis, Coronavirus | Phase 3 | Status: UNKNOWN